The pharmaceutical industry won. The hospital industry lost. After a lobbying fight for the ages between the Pharmaceutical ...

HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit detailed feedback on how the model would ...

When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...

The proposed HRSA 340B rebate model and new manufacturer data submission policies increase administrative burden and create risk of pricing denials and cash flow disruption. These changes could ...

It’s no secret that for working families, the cost of healthcare has spiraled out of control. But much less known is the ...

It's time for lawmakers to finally fix the 340B drug prescription program so it truly benefits our state's most vulnerable ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking behaviors, says the American College of Physicians (ACP). In a new policy, ...

Federal complaints by University of Michigan, University of Kansas Hospital Authority, and Mount Sinai entities seek recovery of approximately $250 million in alleged 340B savings diversion from ...

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide ...

During my time as a state representative, healthcare was always a central part of the debate. I was proud to serve in the House in 2006 when Democratic legislative leadership worked with Republican ...

As regulatory scrutiny increases and manufacturer restrictions continue to evolve, Halo 340B provides an intelligent safety net that transforms 340B management from a high-risk administrative burden ...